Drug reaction with eosinophilia and systemic symptoms: Difference between revisions

From IDWiki
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
== Background ==
== Background ==


*T-cell mediated hypersensitivity reaction
*T-cell mediated [[severe cutaneous adverse reaction]]


== Clinical Manifestations ==
== Clinical Manifestations ==


*Prodrome of fever, malaise, sore throat, dysphagia, pruritus, and a burning sensation on the skin, followed by rash
*Characterized by [[fever]], facial edema, [[maculopapular rash]], [[lymphadenopathy]], [[eosinophilia]], [[atypical lymphocytosis]], and multiorgan dysfunction
*Symptoms include [[fever]], facial edema (which can cause new oblique earlobe creases), [[maculopapular rash]], [[lymphadenopathy]], [[eosinophilia]], [[atypical lymphocytosis]] (earliest and most common hematologic finding), and multiorgan dysfunction
**Includes [[hepatitis]], [[glomerulonephritis]], [[arthritis]], [[pneumonitis]], and [[carditis]]
**Includes [[hepatitis]] (most common organ after skin), [[glomerulonephritis]], [[arthritis]], [[pneumonitis]], and [[carditis]]
*Rash is typically morbilliform and spreads to involve more than 50% total body surface area
**Lesions can be urticarial, eczematous, lichenoid, exfoliative, erythrodermic, targetoid, purpuric, vesicular, pustular, alone or in combination
**About half have mild mucosal involvement
*Typical onset 2 to 8 weeks after starting medication
*Typical onset 2 to 8 weeks after starting medication
*Commonly-associated medications:
*Commonly-associated medications:
**Antibiotics, including [[vancomycin]]
**Antibiotics
***[[Vancomycin]]-associated DRESS is more common in European descendants, with the HLA-A*32:01 allele
***[[Vancomycin]]-associated DRESS is more common in European descendants, with the HLA-A*32:01 allele
***[[Trimethoprim-sulfamethoxazole]]
**[[Antiepileptic]] medications
**[[Antiepileptic]] medications: [[lamotrigine]] and [[carbamazepine]]
**[[Allopurinol]]
**[[Allopurinol]]
*High mortality around 10%
*High mortality around 5%


== DRESS Scoring System ==
== DRESS Scoring System ==
Line 168: Line 173:
|≤1
|≤1
|}
|}

== Management ==

* Cessation of offending medication
* Most common treatment is [[prednisone]] 0.5 to 1 mg/kg (or equivalent glucocorticoid), tapered over 6 to 12 weeks once there is clinical improvement
** No strong evidence to support this practice
* If no improvement with prednisone at regular doses, can consider pulse steroids for 3 days
* People have also tried [[IVIG]], [[Mycobacterium]], [[cyclosporine]], [[cyclophosphamide]], and several biologics (anti-IL5, anti-CD20, JAK inhibitors)
* Resolution is slow, and can recur or relapse, and some patients are left with chronic complications


== Further Reading ==
== Further Reading ==


* The DRESS Syndrome: A Literature Review. ''Am J Med''. 2011;124(7):588-597. doi: [https://doi.org/10.1016/j.amjmed.2011.01.017 10.1016/j.amjmed.2011.01.017]
* The DRESS Syndrome: A Literature Review. ''Am J Med''. 2011;124(7):588-597. doi: [https://doi.org/10.1016/j.amjmed.2011.01.017 10.1016/j.amjmed.2011.01.017]
* Drug Reaction with Eosinophilia and Systemic Symptoms. ''NEJM''. 2024. Doi: [https://doi.org/10.1056/NEJMra2204547 10.1056/NEJMra2204547]


[[Category:Adverse drug reactions]]
[[Category:Adverse drug reactions]]

Latest revision as of 20:35, 17 December 2024

Background

Clinical Manifestations

DRESS Scoring System

  • Developed for RegiSCAR, though I can't seem to find a primary reference

Criteria

Criterion -1 0 1 2 Notes
Fever ≥38.5ºC No/U Yes
Enlarged lymph nodes No/U Yes >1 cm in ≥2 areas
Eosinophilia
—Eosinophils (if WBC ≥4), or 0.7-1.49 ≥1.5
—Eosinophils (if WBC <4) 10-19.9% ≥20%
Atypical lymphocytes No/U Yes
Rash
—Skin rash (%BSA) No/U >50%
—Skin rash suggesting DRESS No U Yes ≥2 of: purpuric lesions (other than legs), infiltration, facial edema, psoriasiform desquamation
—Biopsy suggesting DRESS No Yes/U
Organ involvement
—Liver involvement No/U Yes Maximum score of 2
—Kidney involvement No/U Yes
—Muscle or heart involvement No/U Yes
—Pancreas involvement No/U Yes
—Other organ involvement No/U Yes
Resolution ≥15 days No/U Yes
Exclusion of other causes Yes at least 3 tests were done and negative: HAV, HBV, HCV, ANA, blood cultures, Mycoplasma, Chlamydia

Interpretation

Interpretation Points
Definite ≥6
Probable 4-5
Possible 2-3
Not DRESS ≤1

Management

  • Cessation of offending medication
  • Most common treatment is prednisone 0.5 to 1 mg/kg (or equivalent glucocorticoid), tapered over 6 to 12 weeks once there is clinical improvement
    • No strong evidence to support this practice
  • If no improvement with prednisone at regular doses, can consider pulse steroids for 3 days
  • People have also tried IVIG, Mycobacterium, cyclosporine, cyclophosphamide, and several biologics (anti-IL5, anti-CD20, JAK inhibitors)
  • Resolution is slow, and can recur or relapse, and some patients are left with chronic complications

Further Reading